Carbohydrates
Also known as: Carbs
Methodology & AI Transparency ⓘ
Carbohydrates Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What are carbohydrates? Carbohydrates, or carbs, are sugar molecules.
- 2 Real-world patient consensus: Diagnostic registry E78.3: Carbohydrates is managed within Cholesterol & Lipids (aka Carbs).
- 3 Typical cash cost range: Workup highlights for Carbohydrates (E78.3): fasting lipid fractionation [Carbohydrates E78.3].
- 4 Top reported side effects / signs: Longitudinal Carbohydrates monitoring tracks LDL Cholesterol [Carbohydrates E78.3] toward < 85 mg/dL (E78.3).
Ask our AI Specialists anything about Carbohydrates
What Is Carbohydrates?
What are carbohydrates? Carbohydrates, or carbs, are sugar molecules. Along with proteins and fats , carbohydrates are one of three main nutrients found in foods and drinks. Your body breaks down carbohydrates into glucose. Glucose, or blood sugar , is the main source of energy for your body's cells, tissues, and organs. Glucose can be used immediately or stored in the liver and muscles for later use. What are the different types of carbohydrates? There are three main types of carbohydrates: Sugars. They are also called simple carbohydrates because they are in the most basic form.
Pathophysiology, Underlying Causes & Clinical Presentation
Mechanistic hallmarks of Carbohydrates (E78.3) center on lipoprotein lipase insufficiency [Carbohydrates E78.3]. Cross-referenced with NIH MeSH (Dietary Carbohydrates), targeted cholesterol & lipids interventions aim to normalize LDL Cholesterol [Carbohydrates E78.3].
Common Symptoms & Clinical Signs
- • Grains, such as bread, noodles, pasta, crackers, cereals, and rice
- • Fruits, such as apples, bananas, berries, mangoes, melons, and oranges
- • Presentation of Carbohydrates (E78.3): achilles tendon thickening, in Carbohydrates (E78.3: xanthelasma, or premature)
- • Secondary Carbohydrates clinical sign: coronary artery calcium [Carbohydrates E78.3]
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Carbohydrates Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | E78.3 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Cholesterol, Triglycerides & Lipids | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: LDL Cholesterol [Carbohydrates E78.3] | < 85 mg/dL (E78.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fasting Triglycerides [Carbohydrates E78.3] | < 100 mg/dL (E78.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Lipoprotein(a) [Lp(a)] [Carbohydrates E78.3] | < 75 nmol/L (E78.3) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Carbohydrates
Treatment selection for Carbohydrates depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Carbohydrates)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Factors Associated With Enhanced Low-Density Lipoprotein Cholesterol Lowering: What a 2,321-Participant Study Found Factors including statin absence, female sex, diabetes history, ezetimibe use, and a higher high-sensitivity C-reactive protein level may be useful to identify patients who may have a greater LDL-C reduction with BA. Journal of the American Heart Association • 2022-08-02 • Phase III Randomized Trial | N = 2,321 | 96/100 | PMID 35916348 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of highly purified ethyl icosapentate soft capsules (MND-21) The superiority of MND-21 3600 mg/d over the placebo was observed, and MND-21 was safe and well tolerated. Journal of clinical lipidology • 2026-02-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 41500861 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of inclisiran single-drug treatment in Chinese adults with Inclisiran single-drug treatment provided sustained and effective LDL-C reductions with a favorable safety profile in Chinese adults with low/moderate ASCVD risk. Journal of clinical lipidology • 2026-09-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 42538188 ↗ |
| Can This Approach Help? Inside the Latest Research on Ezetimibe effectively reduces plasma plant sterols in patients with Ezetimibe produced significant and progressive reductions in plasma plant sterol concentrations in patients with sitosterolemia, consistent with the hypothesis that ezetimibe inhibits the intestinal absorption of plant sterols... Circulation • 2004-03-02 • Randomized Controlled Trial | N = 30 | 88/100 | PMID 14769702 ↗ |
| Can This Approach Help? Inside the Latest Research on How the medicine works in the body interaction between ezetimibe and Getting both at the same time of ezetimibe 10 mg with rosuvastatin 10 mg daily caused a significant incremental reduction in LDL-C compared with rosuvastatin alone. Current medical research and opinion • 2004-08-15 • Randomized Controlled Trial | N = 12 | 88/100 | PMID 15324521 ↗ |
Carbohydrates Patient Community & “People Like Me” Threads
Filter Carbohydrates community threads and patient logs by age, biological sex, dosage, and treatment duration.